Medicare reimbursement and prescribing ho... [J Natl Cancer Inst. 2010] - PubMed

Save items

loading

Related citations in PubMed

Reduction in physician reimbursement and use of hormone therapy in prostate cancer. [J Natl Cancer Inst. 2010]
Reduction in physician reimbursement and use of hormone therapy in prostate cancer.
Elliott SP, Jarosek SL, Wilt TJ, Virnig BA. J Natl Cancer Inst. 2010 Dec 15; 102(24):1826-34. Epub 2010 Dec 3.
Review Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. [Evid Rep Technol Assess (Summ)...]
Review Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.
Seidenfeld J, Samson DJ, Aronson N, Albertson PC, Bayoumi AM, Bennett C, Brown A, Garber A, Gere M, Hasselblad V, et al. Evid Rep Technol Assess (Summ). 1999 May; (4):i-x, 1-246, I1-36, passim.
The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer. [J Urol. 2001]
The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer.
Tomera K, Gleason D, Gittelman M, Moseley W, Zinner N, Murdoch M, Menon M, Campion M, Garnick MB. J Urol. 2001 May; 165(5):1585-9.
Timing of androgen deprivation therapy: some questions answered, others not. [J Natl Cancer Inst. 2006]
Timing of androgen deprivation therapy: some questions answered, others not.
Schellhammer PF. J Natl Cancer Inst. 2006 Jun 21; 98(12):802-3.
Review [Total androgen blockade]. [Nihon Rinsho. 2002]
Review [Total androgen blockade].
Namiki M, Mizokami A. Nihon Rinsho. 2002 Dec; 60 Suppl 11:193-8.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Medicare reimbursement and prescribing hormone therapy for prostate cancer.
Medicare reimbursement and prescribing hormone therapy for prostate cancer.
J Natl Cancer Inst. 2010 Dec 15 ;102(24):1814-5. doi: 10.1093/jnci/djq467. Epub 2010 Dec 3 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Medicare reimbursement and prescribing hormone therapy for prostate cancer.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information